Therefore, the aim of this study was to evaluate the expression of CD24, and the ability of anti-SCF to enhance adriamycin by examining their combined effects on both Bcl-2 and annexin V expression in MCF-7 and MCF-7/AdrRes breast cancer cells. This evidence concerns the gene CD24 and breast carcinoma.